Table 2.
Negative Behavioral Change n=18 (22%) |
No Behavioral Change N=64 (78%) |
OR (95% CI) | P-value | |
---|---|---|---|---|
| ||||
Age | ||||
>5 years | 9 (50) | 45 (70) | Referent | |
≤5 years | 9 (50) | 19 (30) | 2.4 (0.8–6.9) | 0.11 |
| ||||
Gender | ||||
Female | 4 (22) | 19 (30) | Referent | |
Male | 14 (78) | 45 (70) | 1.5 (0.4–5.1) | 0.54 |
| ||||
Race* | ||||
White | 8 (47) | 51 (81) | Referent | |
Non-White | 9 (53) | 12 (19) | 4.8 (1.5–15.0) | 0.0072 |
| ||||
Ethnicity | ||||
Non-Hispanic | 17 (94) | 57 (89) | Referent | |
Hispanic | 1 (6) | 7 (11) | 0.5 (0.06–4.2) | 0.51 |
| ||||
Medical conditions | ||||
No | 14 (78) | 56 (87) | Referent | |
Yes | 4 (22) | 8 (13) | 2.0 (0.5–7.6) | 0.31 |
| ||||
Anxiety | ||||
Low | 5 (28) | 44 (69) | Referent | |
High | 13 (72) | 20 (31) | 5.7 (1.8–18.2) | 0.0032 |
| ||||
Sedation duration | ||||
>30 minutes | 16 (89) | 53 (83) | Referent | 0.54 |
≤30 minutes | 2 (11) | 11 (17) | 0.6 (0.1–3.0) | |
| ||||
Midazolam given | ||||
No | 17 (94) | 58 (91) | Referent | |
Yes | 1 (6) | 6 (9) | 0.6 (0.06–5.1) | 0.61 |
One patient in each group did not report race and were left out of the analysis in this category.